BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
145 hedge funds and large institutions have $284M invested in BioDelivery Sciences International, Inc. in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 23 closing their positions.
432% more call options, than puts
Call options by funds: $851K | Put options by funds: $160K
29% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 41
13% more capital invested
Capital invested by funds: $252M → $284M (+$31.6M)
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
1% less funds holding
Funds holding: 147 → 145 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$9.73M |
| 2 |
DM
Deerfield Management
New York
|
+$7.3M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.76M |
| 4 |
BlackRock
New York
|
+$2.68M |
| 5 |
Goldman Sachs
New York
|
+$2.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.27M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$6.18M |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$5.98M |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$3.37M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.3M |
BDSI Hedge Fund Activity: Q4 2020 in Review
145 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2020, worth a combined $284M — up 13% from $252M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of BDSI and 22 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 53 added.
The largest buyer was Wasatch Advisors, adding an estimated $9.73M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $7.27M sold.
- 145 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2020, down from 147 in Q3 2020.
- Funds reported $284M of BioDelivery Sciences International, Inc. stock for Q4 2020, up 13% quarter-over-quarter.
- 22 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2020 and 23 closed out, a net change of -1 holder.
- The largest BioDelivery Sciences International, Inc. buyer in Q4 2020 was Wasatch Advisors, an estimated $9.73M added.
- The largest BioDelivery Sciences International, Inc. seller in Q4 2020 was Adage Capital Partners, an estimated $7.27M sold.
Based on aggregated 13F filings for Q4 2020.